Arbele Revenue and Competitors
Estimated Revenue & Valuation
- Arbele's estimated annual revenue is currently $3.4M per year.
- Arbele's estimated revenue per employee is $155,000
Employee Data
- Arbele has 22 Employees.
- Arbele grew their employee count by -4% last year.
Arbele's People
| Name | Title | Email/Phone |
|---|
Arbele Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.9M | 6 | 0% | N/A | N/A |
#2 | $0.9M | 6 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $5.7M | 37 | 42% | N/A | N/A |
#5 | $1.4M | 18 | -10% | N/A | N/A |
#6 | $3.7M | 48 | -21% | $16M | N/A |
#7 | $1.1M | 7 | 0% | N/A | N/A |
#8 | $0.8M | 5 | -81% | N/A | N/A |
#9 | $2.5M | 16 | -27% | N/A | N/A |
#10 | $0.8M | 5 | -17% | N/A | N/A |
What Is Arbele?
Arbele is a locally grown pharmaceutical biotech focused on immunotherapy of cancers, immune disorders and neurological diseases. The company founding team has a strong combination of business development and pharmaceutical R&D, with an accumulation of >30 year experience in multinational drug companies. Our motto is to excel patient healthcare through innovation and breakthrough. Our mission is to deliver innovative and cost-effective therapeutics to treat diseases of unmet needs. We focus on antibody-based therapeutic platforms, including chimeric antigen receptor (CAR)-T and Bi-specific antibody technology, while leveraging new technology on CRISPR genome editing. Our culture ingredients are “integrity and social valuesâ€.
keywords:N/A
N/A
Total Funding
22
Number of Employees
$3.4M
Revenue (est)
-4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Redmond
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 22 | -15% | N/A |
#2 | $3.9M | 22 | -37% | N/A |
#3 | $4.2M | 22 | -52% | N/A |
#4 | $5.7M | 23 | -8% | N/A |
#5 | $2.4M | 24 | 4% | N/A |